Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Top advances in lymphoma for 2021
Dilan A. Patel
,
Brad S. Kahl
Section of Medical Oncology
Siteman Cancer Center
Research output
:
Contribution to journal
›
Comment/debate
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Top advances in lymphoma for 2021'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Autologous Transplantation
26%
B-Lymphocytes
18%
Cell- and Tissue-Based Therapy
22%
Chimeric Antigen Receptors
97%
Cyclophosphamide
22%
Doxorubicin
22%
Drug Therapy
14%
Elderly
16%
Lymphoma
100%
Lymphoma, Large B-Cell, Diffuse
27%
Pharmaceutical Preparations
9%
Phosphatidylinositol 3-Kinases
23%
Prednisone
24%
Rituximab
26%
Signal Transduction
18%
T-Lymphocytes
59%
Therapeutics
7%
Vincristine
26%
zanubrutinib
51%